Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium : a systematic review and meta-analysis
One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections present a big threat for patients all over the world and treatment with broad-spectrum antibiotics leads to outgrowth of hospital-associated r...
Saved in:
| Published in | Infection and drug resistance Vol. 12; pp. 2713 - 2725 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
New Zealand
Dove Medical Press Limited
01.09.2019
Taylor & Francis Ltd Dove Dove Medical Press |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1178-6973 1178-6973 |
| DOI | 10.2147/IDR.S206084 |
Cover
| Abstract | One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections present a big threat for patients all over the world and treatment with broad-spectrum antibiotics leads to outgrowth of hospital-associated resistant Enterococci clones that are very important in bloodstream infections. We surveyed the frequency and time trend of antibiotic resistance in Enterococci blood isolates from hospitalized patients in different regions of the world.
Literature from January 1, 2000 to May 20, 2018 was searched systematically using Medline (via PubMed), Embase, and Cochrane Library and all original publications on the antibiotic resistance prevalence in blood-isolated Enterococci strains with standard laboratory tests were included. Quality of the included studies was assessed with the modified Critical Appraisal Checklist recommended by the Joanna Briggs Institute. Depending on the heterogeneity test, we used either random or fixed effect models to assess the appropriateness of the pooled prevalence of drug resistance.
A total of 291 studies were enrolled in the meta-analysis. Between all antibiotics, based on the WHO original offices, American countries showed the lowest prevalence of resistance for linezolid in
. Regarding the prevalence of vancomycin resistance, Western Pacific, European, and American countries had the lowest level of resistance and South-East Asia and Eastern Mediterranean countries showed the highest level of resistance. Moreover, our findings for
indicated that America and South-East Asia had the lowest and the highest levels of resistance for linezolid, respectively.
Based on our findings, the prevalence of vancomycin-resistant
in bloodstream infections is significantly high, especially in Eastern Mediterranean countries, which is a massive warning signal for resistance to this broad-spectrum antibiotic. Therefore, the establishment of appropriate antibiotic usage guidelines should be essential in these countries. |
|---|---|
| AbstractList | One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections present a big threat for patients all over the world and treatment with broad-spectrum antibiotics leads to outgrowth of hospital-associated resistant Enterococci clones that are very important in bloodstream infections. We surveyed the frequency and time trend of antibiotic resistance in Enterococci blood isolates from hospitalized patients in different regions of the world.INTRODUCTIONOne of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections present a big threat for patients all over the world and treatment with broad-spectrum antibiotics leads to outgrowth of hospital-associated resistant Enterococci clones that are very important in bloodstream infections. We surveyed the frequency and time trend of antibiotic resistance in Enterococci blood isolates from hospitalized patients in different regions of the world.Literature from January 1, 2000 to May 20, 2018 was searched systematically using Medline (via PubMed), Embase, and Cochrane Library and all original publications on the antibiotic resistance prevalence in blood-isolated Enterococci strains with standard laboratory tests were included. Quality of the included studies was assessed with the modified Critical Appraisal Checklist recommended by the Joanna Briggs Institute. Depending on the heterogeneity test, we used either random or fixed effect models to assess the appropriateness of the pooled prevalence of drug resistance.METHODSLiterature from January 1, 2000 to May 20, 2018 was searched systematically using Medline (via PubMed), Embase, and Cochrane Library and all original publications on the antibiotic resistance prevalence in blood-isolated Enterococci strains with standard laboratory tests were included. Quality of the included studies was assessed with the modified Critical Appraisal Checklist recommended by the Joanna Briggs Institute. Depending on the heterogeneity test, we used either random or fixed effect models to assess the appropriateness of the pooled prevalence of drug resistance.A total of 291 studies were enrolled in the meta-analysis. Between all antibiotics, based on the WHO original offices, American countries showed the lowest prevalence of resistance for linezolid in Enterococcus faecalis. Regarding the prevalence of vancomycin resistance, Western Pacific, European, and American countries had the lowest level of resistance and South-East Asia and Eastern Mediterranean countries showed the highest level of resistance. Moreover, our findings for Enterococcus faecium indicated that America and South-East Asia had the lowest and the highest levels of resistance for linezolid, respectively.RESULTSA total of 291 studies were enrolled in the meta-analysis. Between all antibiotics, based on the WHO original offices, American countries showed the lowest prevalence of resistance for linezolid in Enterococcus faecalis. Regarding the prevalence of vancomycin resistance, Western Pacific, European, and American countries had the lowest level of resistance and South-East Asia and Eastern Mediterranean countries showed the highest level of resistance. Moreover, our findings for Enterococcus faecium indicated that America and South-East Asia had the lowest and the highest levels of resistance for linezolid, respectively.Based on our findings, the prevalence of vancomycin-resistant E. faecium in bloodstream infections is significantly high, especially in Eastern Mediterranean countries, which is a massive warning signal for resistance to this broad-spectrum antibiotic. Therefore, the establishment of appropriate antibiotic usage guidelines should be essential in these countries.CONCLUSIONBased on our findings, the prevalence of vancomycin-resistant E. faecium in bloodstream infections is significantly high, especially in Eastern Mediterranean countries, which is a massive warning signal for resistance to this broad-spectrum antibiotic. Therefore, the establishment of appropriate antibiotic usage guidelines should be essential in these countries. Introduction: One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections present a big threat for patients all over the world and treatment with broad-spectrum antibiotics leads to outgrowth of hospital-associated resistant Enterococci clones that are very important in bloodstream infections. We surveyed the frequency and time trend of antibiotic resistance in Enterococci blood isolates from hospitalized patients in different regions of the world. Methods: Literature from January 1, 2000 to May 20, 2018 was searched systematically using Medline (via PubMed), Embase, and Cochrane Library and all original publications on the antibiotic resistance prevalence in blood-isolated Enterococci strains with standard laboratory tests were included. Quality of the included studies was assessed with the modified Critical Appraisal Checklist recommended by the Joanna Briggs Institute. Depending on the heterogeneity test, we used either random or fixed effect models to assess the appropriateness of the pooled prevalence of drug resistance. Results: A total of 291 studies were enrolled in the meta-analysis. Between all antibiotics, based on the WHO original offices, American countries showed the lowest prevalence of resistance for linezolid in Enterococcus faecalis. Regarding the prevalence of vancomycin resistance, Western Pacific, European, and American countries had the lowest level of resistance and South-East Asia and Eastern Mediterranean countries showed the highest level of resistance. Moreover, our findings for Enterococcus faecium indicated that America and South-East Asia had the lowest and the highest levels of resistance for linezolid, respectively. Conclusion: Based on our findings, the prevalence of vancomycin-resistant E. faecium in bloodstream infections is significantly high, especially in Eastern Mediterranean countries, which is a massive warning signal for resistance to this broad-spectrum antibiotic. Therefore, the establishment of appropriate antibiotic usage guidelines should be essential in these countries. Introduction: One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections present a big threat for patients all over the world and treatment with broad-spectrum antibiotics leads to outgrowth of hospital-associated resistant Enterococci clones that are very important in bloodstream infections. We surveyed the frequency and time trend of antibiotic resistance in Enterococci blood isolates from hospitalized patients in different regions of the world. Methods: Literature from January 1, 2000 to May 20, 2018 was searched systematically using Medline (via PubMed), Embase, and Cochrane Library and all original publications on the antibiotic resistance prevalence in blood-isolated Enterococci strains with standard laboratory tests were included. Quality of the included studies was assessed with the modified Critical Appraisal Checklist recommended by the Joanna Briggs Institute. Depending on the heterogeneity test, we used either random or fixed effect models to assess the appropriateness of the pooled prevalence of drug resistance. Results: A total of 291 studies were enrolled in the meta-analysis. Between all antibiotics, based on the WHO original offices, American countries showed the lowest prevalence of resistance for linezolid in Enterococcus faecalis. Regarding the prevalence of vancomycin resistance, Western Pacific, European, and American countries had the lowest level of resistance and South-East Asia and Eastern Mediterranean countries showed the highest level of resistance. Moreover, our findings for Enterococcus faecium indicated that America and South-East Asia had the lowest and the highest levels of resistance for linezolid, respectively. Conclusion: Based on our findings, the prevalence of vancomycin-resistant E. faecium in bloodstream infections is significantly high, especially in Eastern Mediterranean countries, which is a massive warning signal for resistance to this broad-spectrum antibiotic. Therefore, the establishment of appropriate antibiotic usage guidelines should be essential in these countries. Keywords: drug resistance, Enterococcus faecalis, Enterococcus faecium, prevalence, meta-analysis Seyedeh Marzieh Jabbari Shiadeh,1 Ali Pormohammad,2 Ali Hashemi,1 Parnian Lak31Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Student Research Committee, Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 3Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA, USACorrespondence: Ali PormohammadClinical Microbiology, Shahid Beheshti University of Medical Sciences, Koodakyar Street, Tabnak Blv, Yaman Avenue, Chamran Highway, Tehran, IranTel +98 212 387 2556Fax +98 212 243 9964Email pormohammadali@yahoo.comIntroduction: One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections present a big threat for patients all over the world and treatment with broad-spectrum antibiotics leads to outgrowth of hospital-associated resistant Enterococci clones that are very important in bloodstream infections. We surveyed the frequency and time trend of antibiotic resistance in Enterococci blood isolates from hospitalized patients in different regions of the world.Methods: Literature from January 1, 2000 to May 20, 2018 was searched systematically using Medline (via PubMed), Embase, and Cochrane Library and all original publications on the antibiotic resistance prevalence in blood-isolated Enterococci strains with standard laboratory tests were included. Quality of the included studies was assessed with the modified Critical Appraisal Checklist recommended by the Joanna Briggs Institute. Depending on the heterogeneity test, we used either random or fixed effect models to assess the appropriateness of the pooled prevalence of drug resistance.Results: A total of 291 studies were enrolled in the meta-analysis. Between all antibiotics, based on the WHO original offices, American countries showed the lowest prevalence of resistance for linezolid in Enterococcus faecalis. Regarding the prevalence of vancomycin resistance, Western Pacific, European, and American countries had the lowest level of resistance and South-East Asia and Eastern Mediterranean countries showed the highest level of resistance. Moreover, our findings for Enterococcus faecium indicated that America and South-East Asia had the lowest and the highest levels of resistance for linezolid, respectively.Conclusion: Based on our findings, the prevalence of vancomycin-resistant E. faecium in bloodstream infections is significantly high, especially in Eastern Mediterranean countries, which is a massive warning signal for resistance to this broad-spectrum antibiotic. Therefore, the establishment of appropriate antibiotic usage guidelines should be essential in these countries.Keywords: drug resistance, Enterococcus faecalis, Enterococcus faecium, prevalence, meta-analysis Introduction: One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections present a big threat for patients all over the world and treatment with broad-spectrum antibiotics leads to outgrowth of hospital-associated resistant Enterococci clones that are very important in bloodstream infections. We surveyed the frequency and time trend of antibiotic resistance in Enterococci blood isolates from hospitalized patients in different regions of the world. Methods: Literature from January 1, 2000 to May 20, 2018 was searched systematically using Medline (via PubMed), Embase, and Cochrane Library and all original publications on the antibiotic resistance prevalence in blood-isolated Enterococci strains with standard laboratory tests were included. Quality of the included studies was assessed with the modified Critical Appraisal Checklist recommended by the Joanna Briggs Institute. Depending on the heterogeneity test, we used either random or fixed effect models to assess the appropriateness of the pooled prevalence of drug resistance. Results: A total of 291 studies were enrolled in the meta-analysis. Between all antibiotics, based on the WHO original offices, American countries showed the lowest prevalence of resistance for linezolid in Enterococcus faecalis. Regarding the prevalence of vancomycin resistance, Western Pacific, European, and American countries had the lowest level of resistance and South-East Asia and Eastern Mediterranean countries showed the highest level of resistance. Moreover, our findings for Enterococcus faecium indicated that America and South-East Asia had the lowest and the highest levels of resistance for linezolid, respectively. Conclusion: Based on our findings, the prevalence of vancomycin-resistant E. faecium in bloodstream infections is significantly high, especially in Eastern Mediterranean countries, which is a massive warning signal for resistance to this broad-spectrum antibiotic. Therefore, the establishment of appropriate antibiotic usage guidelines should be essential in these countries. Keywords: drug resistance, Enterococcus faecalis, Enterococcus faecium, prevalence, metaanalysis One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections present a big threat for patients all over the world and treatment with broad-spectrum antibiotics leads to outgrowth of hospital-associated resistant Enterococci clones that are very important in bloodstream infections. We surveyed the frequency and time trend of antibiotic resistance in Enterococci blood isolates from hospitalized patients in different regions of the world. Literature from January 1, 2000 to May 20, 2018 was searched systematically using Medline (via PubMed), Embase, and Cochrane Library and all original publications on the antibiotic resistance prevalence in blood-isolated Enterococci strains with standard laboratory tests were included. Quality of the included studies was assessed with the modified Critical Appraisal Checklist recommended by the Joanna Briggs Institute. Depending on the heterogeneity test, we used either random or fixed effect models to assess the appropriateness of the pooled prevalence of drug resistance. A total of 291 studies were enrolled in the meta-analysis. Between all antibiotics, based on the WHO original offices, American countries showed the lowest prevalence of resistance for linezolid in . Regarding the prevalence of vancomycin resistance, Western Pacific, European, and American countries had the lowest level of resistance and South-East Asia and Eastern Mediterranean countries showed the highest level of resistance. Moreover, our findings for indicated that America and South-East Asia had the lowest and the highest levels of resistance for linezolid, respectively. Based on our findings, the prevalence of vancomycin-resistant in bloodstream infections is significantly high, especially in Eastern Mediterranean countries, which is a massive warning signal for resistance to this broad-spectrum antibiotic. Therefore, the establishment of appropriate antibiotic usage guidelines should be essential in these countries. |
| Audience | Academic |
| Author | Pormohammad, Ali Hashemi, Ali Jabbari Shiadeh, Seyedeh Marzieh Lak, Parnian |
| Author_xml | – sequence: 1 givenname: Seyedeh Marzieh surname: Jabbari Shiadeh fullname: Jabbari Shiadeh, Seyedeh Marzieh – sequence: 2 givenname: Ali orcidid: 0000-0002-7542-4794 surname: Pormohammad fullname: Pormohammad, Ali – sequence: 3 givenname: Ali orcidid: 0000-0002-7258-5541 surname: Hashemi fullname: Hashemi, Ali – sequence: 4 givenname: Parnian surname: Lak fullname: Lak, Parnian |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31564921$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk1tr2zAUx83oWLuuT3sfhsEYDGfWxZa1h0Hpui5QGOzyLI4uThRkq7XkjHyOfeEpTdYlJZRZDxY6v_M_0rk8z45635sse4nKCUaUvZ9--jb5jsu6bOiT7AQh1hQ1Z-RoZ3-cnYWwKNNHeE0ZfpYdE1TVlGN0kv2-cl6Cy28GswRnemVy3-bQRyutj1blgwk2RFgbbJ9L570ubPAOotH5ZR_N4JVXagx5C0aBsyF5H7DYscs_5JCHVYimg4300ppfd3hnIhTQg1ulaC-ypy24YM62_9Ps5-fLHxdfiuuvV9OL8-tCMcJiQTk0HJeIU95whoFXtaSMKF0TzbBGRkrJADcSVU2jOGO85hppWVdNyldbktNsutHVHhbiZrAdDCvhwYq7Az_MBAzpos4IYIRLgpUGYFTSlsuWyKbCDaplyTRKWh83Wjej7IxWpo8DuD3RfUtv52Lml6JmBNGaJoG3W4HB344mRNHZoIxz0Bs_BoEx55SysqwS-voBuvDjkJK3oarUDJj9o2aprsL2rU9x1VpUnNcVbVCVrv84VdLUKJisMzU5QKWlTWdV6sjWpvM92f9z2InwZsdhbsDFeeqyMVrfh33lx8EdxVe7Fbkvxd_eT8C7DaAGH8Jg2nsElWI9XCINl9gOV6LRA1rZCOuo6WXWHfT5AwmDIvw |
| CitedBy_id | crossref_primary_10_1111_lam_13508 crossref_primary_10_1038_s41598_023_47773_7 crossref_primary_10_1038_s41541_024_00940_x crossref_primary_10_1016_j_micpath_2019_103887 crossref_primary_10_31260_RepertMedCir_01217372_1102 crossref_primary_10_3390_pathogens10101310 crossref_primary_10_1007_s11262_023_02016_9 crossref_primary_10_3389_fmicb_2024_1403168 crossref_primary_10_1021_acs_analchem_4c00741 crossref_primary_10_3390_v13030426 crossref_primary_10_3389_fcimb_2021_698807 crossref_primary_10_3389_fmed_2023_1135541 crossref_primary_10_3390_ijms21176345 crossref_primary_10_2174_0109298665266332231001115508 crossref_primary_10_1038_s41598_020_67572_8 crossref_primary_10_1128_AAC_00993_20 crossref_primary_10_47582_jompac_1340041 crossref_primary_10_1002_vms3_761 crossref_primary_10_1016_j_envint_2025_109353 crossref_primary_10_3390_ijms26010011 crossref_primary_10_1186_s12941_024_00689_0 crossref_primary_10_15789_2220_7619_CBE_15452 crossref_primary_10_4103_injms_injms_12_23 crossref_primary_10_3390_microorganisms10112273 crossref_primary_10_1080_14740338_2021_1956459 crossref_primary_10_1002_hsr2_718 crossref_primary_10_1007_s10096_023_04704_8 crossref_primary_10_2334_josnusd_23_0136 crossref_primary_10_3390_microorganisms11010024 crossref_primary_10_3390_tropicalmed6010033 crossref_primary_10_1007_s40477_023_00855_8 crossref_primary_10_1016_j_micpath_2022_105860 crossref_primary_10_2174_0122113525314697240711070000 crossref_primary_10_3389_fmicb_2023_1210319 crossref_primary_10_1139_cjm_2024_0024 crossref_primary_10_3390_antibiotics12071093 crossref_primary_10_1016_j_micres_2024_127771 crossref_primary_10_3389_fphar_2022_891304 crossref_primary_10_1080_22221751_2020_1769500 crossref_primary_10_1111_lam_13686 crossref_primary_10_2478_aoas_2022_0067 crossref_primary_10_1016_j_ijid_2023_01_035 crossref_primary_10_3390_v16081275 crossref_primary_10_1128_IAI_00660_20 crossref_primary_10_1177_22808000241236590 crossref_primary_10_1097_QCO_0000000000000642 crossref_primary_10_1177_10600280241260146 crossref_primary_10_48022_mbl_2409_09009 crossref_primary_10_7759_cureus_49942 crossref_primary_10_5812_jjm_121379 crossref_primary_10_3390_ijms24119727 crossref_primary_10_1093_jambio_lxae126 crossref_primary_10_1021_acs_jmedchem_3c01846 crossref_primary_10_1128_spectrum_02400_21 crossref_primary_10_1080_11263504_2023_2299871 crossref_primary_10_1089_fpd_2020_2827 crossref_primary_10_1097_HJH_0000000000002767 crossref_primary_10_1177_15347346211053936 crossref_primary_10_2334_josnusd_22_0459 crossref_primary_10_1089_mdr_2020_0147 crossref_primary_10_3390_microorganisms11081987 crossref_primary_10_1007_s10123_024_00547_1 crossref_primary_10_1016_j_jgar_2022_03_020 crossref_primary_10_1093_infdis_jiad033 crossref_primary_10_1016_j_pdpdt_2020_101713 crossref_primary_10_1039_D2MD00351A crossref_primary_10_1186_s12941_024_00728_w |
| ContentType | Journal Article |
| Copyright | 2019 Jabbari Shiadeh et al. COPYRIGHT 2019 Dove Medical Press Limited COPYRIGHT 2021 Dove Medical Press Limited 2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2019 Jabbari Shiadeh et al. 2019 Jabbari Shiadeh et al. |
| Copyright_xml | – notice: 2019 Jabbari Shiadeh et al. – notice: COPYRIGHT 2019 Dove Medical Press Limited – notice: COPYRIGHT 2021 Dove Medical Press Limited – notice: 2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2019 Jabbari Shiadeh et al. 2019 Jabbari Shiadeh et al. |
| DBID | AAYXX CITATION NPM 3V. 7XB 8C1 8FE 8FH 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ LK8 M2O M7P MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.2147/IDR.S206084 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) Public Health ProQuest SciTech Collection ProQuest Natural Science Journals ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection (ProQuest) Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection Biological Sciences Proquest Research Library Biological Science Database (Proquest) Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology Public Health |
| DocumentTitleAlternate | Jabbari Shiadeh et al |
| EISSN | 1178-6973 |
| EndPage | 2725 |
| ExternalDocumentID | oai_doaj_org_article_a739b32cdaa74b4f9bf3b852816b07d1 PMC6731464 A654815528 A604315230 31564921 10_2147_IDR_S206084 |
| Genre | Journal Article |
| GeographicLocations | Iran North America San Francisco California United States--US China |
| GeographicLocations_xml | – name: Iran – name: North America – name: San Francisco California – name: China – name: United States--US |
| GroupedDBID | --- 0YH 29I 2WC 53G 5VS 8C1 8FE 8FH 8G5 AAYXX ABUWG ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ C1A CCPQU CITATION DIK DWQXO E3Z EBD FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HYE IAO IHR IHW IPNFZ ITC KQ8 LK8 M2O M48 M7P M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RIG RPM TDBHL UKHRP VDV NPM PJZUB PPXIY PQGLB PMFND 3V. 7XB 8FK MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c737t-49a892019498972a956b473cd63d72d1ebbb7a28b1588c977969d1db658060f03 |
| IEDL.DBID | M48 |
| ISSN | 1178-6973 |
| IngestDate | Wed Aug 27 01:31:26 EDT 2025 Thu Aug 21 13:12:00 EDT 2025 Thu Sep 04 21:08:44 EDT 2025 Fri Jul 25 11:40:14 EDT 2025 Tue Jun 17 21:32:00 EDT 2025 Tue Jun 17 21:20:43 EDT 2025 Tue Jun 10 20:53:29 EDT 2025 Tue Jun 10 20:34:42 EDT 2025 Thu May 22 21:22:59 EDT 2025 Thu May 22 21:22:19 EDT 2025 Mon Jul 21 06:06:39 EDT 2025 Tue Jul 01 04:16:15 EDT 2025 Thu Apr 24 23:02:55 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Enterococcus faecalis meta-analysis Enterococcus faecium prevalence drug resistance |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/3.0 2019 Jabbari Shiadeh et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c737t-49a892019498972a956b473cd63d72d1ebbb7a28b1588c977969d1db658060f03 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-7258-5541 0000-0002-7542-4794 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/IDR.S206084 |
| PMID | 31564921 |
| PQID | 2299560827 |
| PQPubID | 3933157 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_a739b32cdaa74b4f9bf3b852816b07d1 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6731464 proquest_miscellaneous_2299447005 proquest_journals_2299560827 gale_infotracmisc_A654815528 gale_infotracmisc_A604315230 gale_infotracacademiconefile_A654815528 gale_infotracacademiconefile_A604315230 gale_healthsolutions_A654815528 gale_healthsolutions_A604315230 pubmed_primary_31564921 crossref_primary_10_2147_IDR_S206084 crossref_citationtrail_10_2147_IDR_S206084 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-09 |
| PublicationDateYYYYMMDD | 2019-09-01 |
| PublicationDate_xml | – month: 09 year: 2019 text: 2019-09 |
| PublicationDecade | 2010 |
| PublicationPlace | New Zealand |
| PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
| PublicationTitle | Infection and drug resistance |
| PublicationTitleAlternate | Infect Drug Resist |
| PublicationYear | 2019 |
| Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
| Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
| SSID | ssj0000396472 |
| Score | 2.4678156 |
| SecondaryResourceType | review_article |
| Snippet | One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials. Nosocomial infections... Introduction: One of the global concerns is the increasing trend toward antimicrobial resistance and the consequent lack of efficient antimicrobials.... Seyedeh Marzieh Jabbari Shiadeh,1 Ali Pormohammad,2 Ali Hashemi,1 Parnian Lak31Department of Microbiology, School of Medicine, Shahid Beheshti University of... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 2713 |
| SubjectTerms | Analysis Antibacterial agents Antibiotic resistance Antibiotics Antimicrobial agents Antimicrobial resistance Blood Citations Developing countries Drug resistance Drug resistance in microorganisms Enterococcus faecalis Enterococcus faecium Gram-positive bacteria Health aspects Hospital patients Hospitalization Hospitals Infection Laboratory animals LDCs Linezolid Meta-Analysis Methods Microbial drug resistance Microbiology Morbidity Mortality Nosocomial infection Nosocomial infections Patients prevalence Public health Review Studies Surveys Systematic review Tigecycline Vancomycin |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQbwItGKkqEmpoYmf94FYeVUECVdBKvVm2k4hINKn2cejf6C9mxk6ziVjUC9f12NqdGX-eWc18Q8hu7pStIZdNpYfrhjOsUy1ylyqe1y5ntbahqvLbd3F8Vnw9n52PRn1hTVikB46KO7CSa8eZL62VhStq7Wru1IypXLhMliHxyXQ2SqYCBnPssGRxsopKhZY8NufhWJ6Dppy_W7BMBE7T0XMUWPv_xubR4zQtnBy9REf3yb0-hKSH8as_IHeq9iHZO4kc1Ff79HTdUrXYp3v0ZM1OffWIXEeWf3o5R6JvvNe0qynot3FNB1so5N8YU-JC09JY2N6Ah0JQWtJQQ9ABiPrVgta28sifCLs3rDSri_fU0jVVNI1tMkH6olra1PaEKI_J2dHn04_HaT-YIfWSy2VaaKs0RA660EpLZiHHcoXkvhS8lKzMK-ectEy5fKaUhwhTC13mpYNoB5ReZ_wJ2Wq7tnpGqPdVCRGDswKAwc-EVbbAPjChamczrxPy9sY-xves5Tg847eB7AWNab58-mF-RmMmZHcQvoxkHZvFPqChBxFk2A4fgN-Z3u_MbX6XkFfoJia2qw44YQ4F0hXhf-3_lpghQw4clZA3QQKxBH6Ut31LBKgGWbkmZ90muT5zeyIJaOEnB21cHu2-8XrTg9nCMIbtzxAryoS8HpZxJxbotVW3ijJFIQHTE_I0XpJBvxwJiTQDlcnJ9ZkYYLrSNr8C1bmQHJ7y4vn_sNgLchd9NhYIbpOt5XxV7UBEuXQvA3j8ASOXc5w priority: 102 providerName: Directory of Open Access Journals – databaseName: Public Health dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagXJAQgvIKFDBSVSTUtGs76wcXVApVQQJV0Eq9RbaTQCSaLPs49G_wi5mJvdmNKHBdj61dj-fzeHbmG0K2mdO2grdsqjyYG_awTo1kLtWCVY7xytguq_LTZ3l8ln08H5_HgNssplUuMbED6qL1GCPf5xxrMOHCUm8mP1PsGoX_rsYWGtfJDQYYjIapD1kfYxkJrLPkoSwPG_Lsf3j3Ze8rH8mOzXTtIur4-v9E5bVraZgyuXYHHd0ht6PzSA-Ctu-Sa2WzSXZOAvv05S49XRVTzXbpDj1Z8VJfbpJbIURHQ-XRPfIr8P3TyRQpv9HCaVtR2Ona1S0sQeEljt4lDtQNDSnuNZxVcE8L2mUTtACnfjGjlS09MinC7CtG6sXFa2rpijSahoKZTvqinNvURmqU--Ts6P3p4XEaWzSkXgk1TzNjtQEfwmRGG8UtqMhlSvhCikLxgpXOOWW5dmystQdf00hTsMKB3wNKqEbiAdlo2qZ8RKj3ZQG-g7MSIMKPpdU2w4owqStnR94k5NVSX7mP_OXYRuNHDu8YVG4Oys2jchOy3QtPAm3H1WJvUfG9CHJtdx-00295NN3cKmGc4L6wVmUuq4yrhNNjrpl0I1WwhDzHY5OHwtUeMfIDicRFGHX_u8QYuXJgqYS87CQQVeBHeRuLI2BrkJ9rsNb_JFdrbg0kATf8YKErh9dmL60gj7A2y1dGmJAX_TDOxFS9pmwXQSbLFKB7Qh4Go-n3VyA1keGwZWpgTgMFDEea-ntHei6VgEs9e_zvr_WE3MTTGJIAt8jGfLoon4LXOHfPOmj4DQ1ZbQw priority: 102 providerName: ProQuest |
| Title | Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium : a systematic review and meta-analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31564921 https://www.proquest.com/docview/2299560827 https://www.proquest.com/docview/2299447005 https://pubmed.ncbi.nlm.nih.gov/PMC6731464 https://doaj.org/article/a739b32cdaa74b4f9bf3b852816b07d1 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Zb9QwELZ6vPCCuAmUxUhVkVDTbmKvDySE2tJSkFqtSlfqW2Q7CURqk7KHxP4NfjEzcfYILOpLHuKxpczlmWjmG0K2I6tMDrlsKB2YG86wDrWIbKhYlNsozrWpqyrPzsXpgH-96l2tkdkwzoaBo5WpHc6TGgyv9379nH4Eg_-AZcwRl_tFOtwbxV3RVXydbMKVJDALO2vi_NolM2y4jP2gFRUKLZnv1ft7f-t2qkH8_3XVS3dVu45y6WI6eUDuNxElPfAq8JCsZeUjstP3kNTTXXq56LAa7dId2l-AVU8fk98e9J_eDhH3G82cVjkFdhe2qGALhXQcQ0xcKErq69wLUFiIUVNalxRU4FPdZERzkzmEU4TdK1aKyc17augCOZr6rpma-iYbm9A0-ChPyODk-PLoNGzmNIROMjkOuTZKQyChuVZaxgZSLsslc6lgqYzTKLPWShMrG_WUchBwaqHTKLUQ_ADT8y57SjbKqsyeE-pclkIAYY0AP-F6wijDsS1MqNyartMBeTeTT-IaEHOcpXGdQDKDwky-fLpIvnlhBmR7TnzrsTtWkx2ioOckCLhdv6iG35PGfhMjmbYsdqkxkluea5szq3qxioTtyjQKyGtUk8R3r87dRnIgEL0If73_n6KHgDlwVEDe1hSo7PBRzjQdEsAaBOlqnXUX5eLMrRYlOA_XOmjl8tLumdYnM9NM4hi7oSF0lAF5M1_GnVivV2bVxNNwLsHFB-SZN5I5fxniE-kYWCZb5tMSQHulLH7UyOdCMrjZ-Ys7mf2S3EOF9MWAW2RjPJxkryB6HNsOWVdHUYdsHh6f9y869T8YeH6-gnfoM_4Agihyfw |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELbG-AASQjDeCoMZaQwJLSyx09hGQmhsTC170cQ6ad-C7SQQiSWlL0L9G_wQfiN3cfoSUeDTvtbnU-uznzu7d88RshkYqTO4y3rCwnHDHtaeigLjSR5kJmCZ0lVW5fFJ1DkPP160L1bIr2ktDKZVTjGxAuqktPhGvsMY1mCCwxLv-t897BqF_65OW2i4bXGYTn7AlW34trsP9n3B2MGH3l7Hq7sKeFZwMfJCpaUCt6dCJZVgGrSaUHCbRDwRLAlSY4zQTJqgLaWF8EhFKgkSA67aj_zM56D3Grkech5hCpncC2ZvOj7Huk7mygCxAdBOd__T6zMG82TYcHxVf4A_vcCCG2ymaC74vIM75HYdrNJdt7vukpW0WCNbp47terJNe_PireE23aKncx7syRq55Z4Eqat0ukd-uv4CtD9AinFEFFpmFCybm7wEFRRu_hjN4kBeUJdSn8PZgHA4oVX2QgnwbcdDmunUInMjzF4yko8v31BN5yTV1BXoVNKX6Uh7uqZiuU_Or8R4D8hqURbpI0KtTROIVYyOAJJsO9JSh1iBFsnMaN-qFnk1tVdsa750bNvxLYZ7Exo3BuPGtXFbZHMm3Hc0IcvF3qPhZyLI7V19UA6-xDVUxFpwZTizidYiNGGmTMaNbDMZRMYXSdAiG7htYlcoO0OoeDdCoiR85f-7RBu5eUBVi7ysJBDF4EdZXRdjwNIgH1hD1_8k5zrXG5KAU7ahaOnwwuzpKYhrGB3G80PfIs9nwzgTUwOLtBw7mTAU4E1a5KE7NLP15UiFpBgsmWgcp4YBmiNF_rUiWY8EhyAifPzvr7VBbnR6x0fxUffk8Am5iTvTJSCuk9XRYJw-hYh1ZJ5VMEHJ56vGpd-GaKfa |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELZGJyEkhGC8BQYz0hgSWmjipHGMNKGNbloZVNVepH0LtpNAJJaUvgj1b_Cz-FXcxWnaiAKf9rU-X1tf_NzZuXuOkG1XhTKFs6zNNWw37GFti8BVdui5qXJZKmSZVfmpHxxf-B8uO5dr5Ne8FgbTKueYWAJ1XGi8I28zhjWY4LB4O63SIgbdo3fD7zZ2kMI3rfN2GrJqsxDvlXRjVZHHSTL7Ace58V6vC7Z_ydjR4fn7Y7vqOGBr7vGJ7QsZCnCJwheh4EzCNyqfezoOvJiz2E2UUlyyULmdMNQQOolAxG6swI07gZM6Hui9QdY5eEnWIusHh_3BaX3j43hY9clMkSC2B2r3uqdvzhjMDP2GWyy7B_zpI5acZDOBc8kjHt0ld6pQlu6bZ-8eWUvyDbIzMFzYs116vijtGu_SHTpYsGTPNshtc2FITR3UffLTdB-gwxESkCPe0CKlYPdMZQWooKNkjLEuDmQ5NQn3GewcCJZjWuY2FADuejqmqUw08jrC7BUj2fTqLZV0QWFNTflOKX2VTKQtK6KWB-TiWsz3kLTyIk8eE6p1EkMko2QAgKU7gQylj_VpQZgq6Whhkddze0W6YlPHph7fIjhVoXEjMG5UGdci27Xw0JCIrBY7QMPXIsj8XX5QjL5EFZBEkntCeUzHUnJf-alQqafCDgvdQDk8di2yhY9NZMpoa_yK9gOkUcJ3AH-X6CBzD6iyyKtSAjEO_pSWVakGLA2yhTV0_U9yoXOzIQkophuKVg4vzZ7vgqgC2XG0gASLvKiHcSYmDuZJMTUyvs_B11jkkdk09fp6SJQkGCwZb2ynhgGaI3n2taRgD7gHIYb_5N8_a4vcBIyKPvb6J0_JLXwwTXbiJmlNRtPkGYSzE_W8wglKPl83NP0G4C2y0Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+prevalence+of+antibiotic+resistance+in+blood-isolated+Enterococcus+faecalis+and+Enterococcus+faecium%3A+a+systematic+review+and+meta-analysis&rft.jtitle=Infection+and+drug+resistance&rft.au=Hashemi%2C+Ali&rft.au=Lak%2C+Parnian&rft.au=Shiadeh%2C+Seyedeh+Marzieh+Jabbari&rft.au=Pormohammad%2C+Ali&rft.date=2019-09-01&rft.pub=Dove+Medical+Press+Limited&rft.issn=1178-6973&rft.eissn=1178-6973&rft.spage=2713&rft_id=info:doi/10.2147%2Fidr.s206084&rft.externalDBID=n%2Fa&rft.externalDocID=A604315230 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-6973&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-6973&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-6973&client=summon |